Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A multicenter phase II rater-blinded randomized controlled trial to compare the effectiveness of eye movement desensitization reprocessing therapy vs. Treatment as usual in patients with substance use disorder and history of psychological trauma, A study design and protocol

  • Valiente-Gómez, Alicia|||0000-0003-0220-2397
  • Moreno Alcázar, Ana|||0000-0002-3392-5590
  • Radua, Joaquim|||0000-0003-1240-5438
  • Hogg, Bridget|||0000-0002-2405-0593
  • Blanco Presas, Laura|||0000-0001-6272-4416
  • Lupo, Walter
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Robles-Martínez, María|||0000-0003-0324-8354
  • Torrens, Marta|||0000-0001-6222-4761
  • Amann, Benedikt L.|||0000-0002-4407-1519
Background: Psychological trauma has a strong negative impact on the onset, course and prognosis of substance use disorders (SUD). Few trauma-oriented treatment approaches have been trialed, but preliminary evidence exists of the efficacy of Eye Movement Desensitization and Reprocessing (EMDR) therapy in improving clinical symptoms in SUD patients. Objective: To assess if EMDR therapy leads to: (1) reduced substance consumption; (2) an improvement in psychopathological and in trauma-related symptoms; and (3) an improvement in overall functioning. Our hypothesis is that the EMDR group will improve in all variables when compared to the treatment as usual (TAU) group at 6 and 12-months visits. Method: In this multicenter phase II rater-blinded randomized controlled trial, 142 SUD patients with a history of psychological trauma will be randomly assigned to EMDR (n = 71) or to TAU (n = 71). Patients in the EMDR group will receive 20 psychotherapeutic sessions of 60 min over 6 months. Substance use will be measured using the Timeline Followback Questionnaire, the Dependence Severity Scale and the Visual Analog Scale. Traumatic events will be measured by The Holmes-Rahe Life Stress Inventory, the Childhood Trauma Questionnaire Scale, the Global Assessment of Posttraumatic Stress Questionnaire, the Impact of Event Scale-Revised and the Dissociative Experiences Scale. Clinical symptomatology will be evaluated using the Hamilton Depression Rating Scale, the Young Mania Rating Scale and the Brief Psychiatric Rating Scale. Functionality will be assessed with the Functioning Assessment Short Test. All variables will be measured at baseline, post-treatment and 12 months as follow-up. Primary outcome: to test the efficacy of EMDR therapy in reducing the severity of substance use. The secondary outcomes: to test the efficacy in reducing trauma-related psychological symptoms and psychopathological symptoms and in improving overall functioning in patients with comorbid SUD and a history of psychological trauma. Conclusion: This study will provide evidence of whether EMDR therapy is effective in reducing addiction-related, trauma and clinical symptoms and in improving functionality in patients with SUD and a history of trauma.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Traumatic events in dual disorders, prevalence and clinical characteristics

  • Blanco Presas, Laura|||0000-0001-6272-4416
  • Sió, Albert
  • Hogg, Bridget|||0000-0002-2405-0593
  • Esteve-Puig, R.|||0000-0003-0547-1752
  • Radua, Joaquim|||0000-0003-1240-5438
  • Solanes, Aleix|||0000-0002-2491-200X
  • Gardoki-Souto, Itxaso|||0000-0002-0775-1275
  • Sauras, Rosa
  • Farré Martínez, Adriana|||0000-0001-5399-9389
  • Castillo, Claudio
  • Valiente Gomez, Alicia|||0000-0003-0220-2397
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Torrens, Marta
  • Amann, Benedikt L.|||0000-0002-4407-1519
  • Moreno Alcázar, Ana|||0000-0002-3392-5590
Psychological trauma has been identified in substance use disorders (SUD) as a major etiological risk factor. However, detailed and systematic data about the prevalence and types of psychological trauma in dual disorders have been scarce to date. In this study, 150 inpatients were recruited and cross-sectionally screened on their substance use severity, psychological trauma symptoms, comorbidities, and clinical severity. One hundred patients fulfilled criteria for a dual disorder, while 50 patients were diagnosed with only SUD. Ninety-four percent of the whole sample suffered from at least one lifetime traumatic event. The prevalence rates of Posttraumatic Stress Disorder diagnosis for dual disorder and only SUD was around 20% in both groups; however, patients with dual disorder presented more adverse events, more childhood trauma, more dissociative symptoms, and a more severe clinical profile than patients with only SUD. Childhood maltreatment can also serve as a predictor for developing a dual disorder diagnosis and as a risk factor for developing a more complex and severe clinical profile. These data challenge our current clinical practice in the treatment of patients suffering from dual disorder or only SUD diagnosis and favor the incorporation of an additional trauma-focused therapy in this population. This may improve the prognosis and the course of the illness in these patients.